ADAM9 disintegrin domain activates human neutrophils through an autocrine circuit involving integrins and cxcr2

Journal of Leukocyte Biology

Volumn 97, Issue 5, 2015, Pages 951-962

  Amendola, Rafael S ^a   Martin, Ana Carolina B M ^b   Selistre De Araújo, Heloísa S ^b   Paula Neto, Heitor A ^a,c   Saldanha Gama, Roberta ^a   Barja Fidalgo, Christina ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Apoptosis; Chemotaxis; Granulocyte; IL 8; Signal transduction

Indexed keywords

ADAM PROTEIN; ADAM9 PROTEIN; ALPHA9BETA1 INTEGRIN; CASPASE 3; CHEMOKINE RECEPTOR CXCR2; CYTOCHALASIN D; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTEGRIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROCASPASE 3; PROTEIN KINASE B; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL SHAPE; CYTOSKELETON; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; LEUKOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 84929208108     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3A0914-455R     Document Type: Article

References (58)

1. Nauseef, W. M., Borregaard, N. (2014) Neutrophils at work. Nat. Immunol. 15, 602–611.
2. Bardoel, B. W., Kenny, E. F., Sollberger, G., Zychlinsky, A. (2014) The balancing act of neutrophils. Cell Host Microbe 15, 526–536.
3. Smith, C. W., Rothlein, R., Hughes, B. J., Mariscalco, M. M., Rudloff, H. E., Schmalstieg, F. C., Anderson, D. C. (1988) Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration. J. Clin. Invest. 82, 1746–1756.
4. Gonzalez, A. L., El-Bjeirami, W., West, J. L., McIntire, L. V., Smith, C. W. (2007) Transendothelial migration enhances integrin-dependent human neutrophil chemokinesis. J. Leukoc. Biol. 81, 686–695.
5. Ley, K., Laudanna, C., Cybulsky, M. I., Nourshargh, S. (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678–689.
6. Berton, G., Yan, S. R., Fumagalli, L., Lowell, C. A. (1996) Neutrophil activation by adhesion: mechanisms and pathophysiological implications. Int. J. Clin. Lab. Res. 26, 160–177.
7. Streuli, C. H. (2009) Integrins and cell-fate determination. J. Cell Sci. 122, 171–177.
8. Lawrence, M. B., Springer, T. A. (1991) Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65, 859–873.
9. Nath, D., Slocombe, P. M., Webster, A., Stephens, P. E., Docherty, A. J. P., Murphy, G. (2000) Meltrin g(ADAM-9) mediates cellular adhesion through a(6)b(1)integrin, leading to a marked induction of fibroblast cell motility. J. Cell Sci. 113, 2319–2328.
10. Eto, K., Huet, C., Tarui, T., Kupriyanov, S., Liu, H. Z., Puzon-McLaughlin, W., Zhang, X. P., Sheppard, D., Engvall, E., Takada, Y. (2002) Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions. J. Biol. Chem. 277, 17804–17810.
11. Bridges, L. C., Hanson, K. R., Tani, P. H., Mather, T., Bowditch, R. D. (2003) Integrin alpha4beta1-dependent adhesion to ADAM 28 (MDC-L) requires an extended surface of the disintegrin domain. Biochemistry 42, 3734–3741.
12. Sun, C., Wu, M. H., Guo, M., Day, M. L., Lee, E. S., Yuan, S. Y. (2010) ADAM15 regulates endothelial permeability and neutrophil migration via Src/ERK1/2 signalling. Cardiovasc. Res. 87, 348–355.
13. Duffy, M. J., McKiernan, E., O’Donovan, N., McGowan, P. M. (2009) The role of ADAMs in disease pathophysiology. Clin. Chim. Acta 403, 31–36.
14. Sahin, U., Weskamp, G., Kelly, K., Zhou, H. M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P., Blobel, C. P. (2004) Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164, 769–779.
15. Bell, J. H., Herrera, A. H., Li, Y., Walcheck, B. (2007) Role of ADAM17 in the ectodomain shedding of TNF-a and its receptors by neutrophils and macrophages. J. Leukoc. Biol. 82, 173–176.
16. Möller-Hackbarth, K., Dewitz, C., Schweigert, O., Trad, A., Garbers, C., Rose-John, S., Scheller, J. (2013) A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3). J. Biol. Chem. 288, 34529–34544.
17. Pruessmeyer, J., Hess, F. M., Alert, H., Groth, E., Pasqualon, T., Schwarz, N., Nyamoya, S., Kollert, J., van der Vorst, E., Donners, M., Martin, C., Uhlig, S., Saftig, P., Dreymueller, D., Ludwig, A. (2014) Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space. Blood 123, 4077–4088.
18. Zigrino, P., Nischt, R., Mauch, C. (2011) The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts. J. Biol. Chem. 286, 6801–6807.
19. Namba, K., Nishio, M., Mori, K., Miyamoto, N., Tsurudome, M., Ito, M., Kawano, M., Uchida, A., Ito, Y. (2001) Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes. Cell. Immunol. 213, 104–113.
20. Oksala, N., Levula, M., Airla, N., Pelto-Huikko, M., Ortiz, R. M., Järvinen, O., Salenius, J. P., Ozsait, B., Komurcu-Bayrak, E., Erginel-Unaltuna, N., Huovila, A. P., Kytöömäki, L., Soini, J. T., Kähönen, M., Karhunen, P. J., Laaksonen, R., Lehtimäki, T. (2009) ADAM-9, ADAM-15, and ADAM-17 are upregulated in macrophages in advanced human atherosclerotic plaques in aorta and carotid and femoral arteries—Tampere vascular study. Ann. Med. 41, 279–290.
21. Shintani, Y., Higashiyama, S., Ohta, M., Hirabayashi, H., Yamamoto, S., Yoshimasu, T., Matsuda, H., Matsuura, N. (2004) Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res. 64, 4190–4196.
22. Peduto, L., Reuter, V. E., Shaffer, D. R., Scher, H. I., Blobel, C. P. (2005) Critical function for ADAM9 in mouse prostate cancer. Cancer Res. 65, 9312–9319.
23. Zigrino, P., Mauch, C., Fox, J. W., Nischt, R. (2005) Adam-9 expression and regulation in human skin melanoma and melanoma cell lines. Int. J. Cancer 116, 853–859.
24. Fritzsche, F. R., Wassermann, K., Jung, M., Tölle, A., Kristiansen, I., Lein, M., Johannsen, M., Dietel, M., Jung, K., Kristiansen, G. (2008) ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer 8, 179.
25. Fry, J. L., Toker, A. (2010) Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration. Cancer Res. 70, 8187–8198.
26. Roychaudhuri, R., Hergrueter, A. H., Polverino, F., Laucho-Contreras, M. E., Gupta, K., Borregaard, N., Owen, C. A. (2014) ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury. J. Immunol. 193, 2469–2482.
27. Mazzocca, A., Coppari, R., De Franco, R., Cho, J. Y., Libermann, T. A., Pinzani, M., Toker, A. (2005) A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res. 65, 4728–4738.
28. Jia, L. G., Shimokawa, K., Bjarnason, J. B., Fox, J. W. (1996) Snake venom metalloproteinases: structure, function and relationship to the ADAMs family of proteins. Toxicon 34, 1269–1276.
29. Karadag, A., Zhou, M., Croucher, P. I. (2006) ADAM-9 (MDC-9/meltringamma), a member of the a disintegrin and metalloproteinase family, regulates myeloma-cell-induced interleukin-6 production in osteoblasts by direct interaction with the alpha(v)beta5 integrin. Blood 107, 3271–3278.
30. Cominetti, M. R., Martin, A. C., Ribeiro, J. U., Djaafri, I., Fauvel-Laféve, F., Crépin, M., Selistre-de-Araujo, H. S. (2009) Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions. Biochimie 91, 1045–1052.
31. Jamieson, T., Clarke, M., Steele, C. W., Samuel, M. S., Neumann, J., Jung, A., Huels, D., Olson, M. F., Das, S., Nibbs, R. J., Sansom, O. J. (2012) Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 122, 3127–3144.
32. Gong, L., Cumpian, A. M., Caetano, M. S., Ochoa, C. E., De la Garza, M. M., Lapid, D. J., Mirabolfathinejad, S. G., Dickey, B. F., Zhou, Q., Moghaddam, S. J. (2013) Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase. Mol. Cancer 12, 154.
33. Jablonska, J., Wu, C. F., Andzinski, L., Leschner, S., Weiss, S. (2014) CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-b. Int. J. Cancer 134, 1346–1358.
34. Coelho, A. L., De Freitas, M. S., Mariano-Oliveira, A., Oliveira-Carvalho, A. L., Zingali, R. B., Barja-Fidalgo, C. (2001) Interaction of disintegrins with human neutrophils induces cytoskeleton reorganization, focal adhesion kinase activation, and extracellular-regulated kinase-2 nuclear translocation, interfering with the chemotactic function. FASEB J. 15, 1643–1645.
35. Saldanha-Gama, R. F., Moraes, J. A., Mariano-Oliveira, A., Coelho, A. L., Walsh, E. M., Marcinkiewicz, C., Barja-Fidalgo, C. (2010) alpha(9)beta(1) Integrin engagement inhibits neutrophil spontaneous apoptosis: involvement of Bcl-2 family members. Biochim. Biophys. Acta 1803, 848–857.
36. Marcinkiewicz, C., Rosenthal, L. A., Mosser, D. M., Kunicki, T. J., Niewiarowski, S. (1996) Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins. Biochem. J. 317, 817–825.
37. Nathan, C. F. (1987) Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J. Clin. Invest. 80, 1550–1560.
38. Mahimkar, R. M., Visaya, O., Pollock, A. S., Lovett, D. H. (2005) The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins. Biochem. J. 385, 461–468.
39. Hirsch, E., Katanaev, V. L., Garlanda, C., Azzolino, O., Pirola, L., Silengo, L., Sozzani, S., Mantovani, A., Altruda, F., Wymann, M. P. (2000) Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287, 1049–1053.
40. Heit, B., Liu, L., Colarusso, P., Puri, K. D., Kubes, P. (2008) PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP. J. Cell Sci. 121, 205–214.
41. Coelho, A. L., De Freitas, M. S., Mariano-Oliveira, A., Rapozo, D. C., Pinto, L. F., Niewiarowski, S., Zingali, R. B., Marcinkiewicz, C., Barja- Fidalgo, C. (2004) RGD- and MLD-disintegrins, jarastatin and EC3, activate integrin-mediated signaling modulating the human neutrophils chemotaxis, apoptosis and IL-8 gene expression. Exp. Cell Res. 292, 371–384.
42. Paula-Neto, H. A., Alves-Filho, J. C., Souto, F. O., Spiller, F., Amˆendola, R. S., Freitas, A., Cunha, F. Q., Barja-Fidalgo, C. (2011) Inhibition of guanylyl cyclase restores neutrophil migration and maintains bactericidal activity increasing survival in sepsis. Shock 35, 17–27.
43. Walther, A., Riehemann, K., Gerke, V. (2000) A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell 5, 831–840.
44. Cotton, M., Claing, A. (2009) G Protein-coupled receptors stimulation and the control of cell migration. Cell. Signal. 21, 1045–1053.
45. Zarbock, A., Ley, K. (2008) Mechanisms and consequences of neutrophil interaction with the endothelium. Am. J. Pathol. 172, 1–7.
46. Mariano-Oliveira, A., Coelho, A. L., Terruggi, C. H., Selistre-de-Araújo, H. S., Barja-Fidalgo, C., De Freitas, M. S. (2003) Alternagin-C, a nonRGDdisintegrin, induces neutrophil migration via integrin signaling. Eur. J. Biochem. 270, 4799–4808.
47. Arruda, M. A., Barcellos-de-Souza, P., Sampaio, A. L., Rossi, A. G., Graça- Souza, A. V., Barja-Fidalgo, C. (2006) NADPH oxidase-derived ROS: key modulators of heme-induced mitochondrial stability in human neutrophils. Exp. Cell Res. 312, 3939–3948.
48. Stanton, K. J., Frewin, M. B., Gudewicz, P. W. (1999) Heterologous desensitization of IL-8-mediated chemotaxis in human neutrophils by a cell-binding fragment of fibronectin. J. Leukoc. Biol. 65, 515–522.
49. Heit, B., Tavener, S., Raharjo, E., Kubes, P. (2002) An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol. 159, 91–102.
50. Hu, Q., Klippel, A., Muslin, A. J., Fantl, W. J., Williams, L. T. (1995) Rasdependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268, 100–102.
51. Liu, X., Ma, B., Malik, A. B., Tang, H., Yang, T., Sun, B., Wang, G., Minshall, R. D., Li, Y., Zhao, Y., Ye, R. D., Xu, J. (2012) Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases. Nat. Immunol. 13, 457–464.
52. Moraes, J., Assreuy, J., Canetti, C., Barja-Fidalgo, C. (2010) Leukotriene B4 mediates vascular smooth muscle cell migration through avb3 integrin transactivation. Atherosclerosis 212, 406–413.
53. Halliday, G. M., Le, S. (2001) Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin. Int. Immunol. 13, 1147–1154.
54. Bekeredjian-Ding, I., Schäfer, M., Hartmann, E., Pries, R., Parcina, M., Schneider, P., Giese, T., Endres, S., Wollenberg, B., Hartmann, G. (2009) Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha. Immunology 128, 439–450.
55. Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., Albelda, S. M. (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell 16, 183–194.
56. Demers, M., Krause, D. S., Schatzberg, D., Martinod, K., Voorhees, J. R., Fuchs, T. A., Scadden, D. T., Wagner, D. D. (2012) Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancerassociated thrombosis. Proc. Natl. Acad. Sci. USA 109, 13076–13081.
57. Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., Ferri, L. (2013) Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Invest. 123, 3446–3458.
58. Jenne, C. N., Kubes, P. (2013) Immune surveillance by the liver. Nat. Immunol. 14, 996–1006.